Pallister Hall Syndrome, also known as PHS, is a rare genetic disorder that affects multiple systems in the body. It is characterized by a wide range of symptoms and can vary in severity from person to person.
Synonyms for Pallister Hall Syndrome:
Pallister Hall Syndrome is caused by mutations in the GLI3 gene, which plays a crucial role in the development of various organs and tissues during embryonic development. The disorder is inherited in an autosomal dominant manner, meaning that a mutation in only one copy of the gene is sufficient to cause the condition.
Common symptoms of Pallister Hall Syndrome include:
Due to the wide range of symptoms and their variability, diagnosis of Pallister Hall Syndrome can be challenging. Genetic testing is typically required to confirm the presence of GLI3 gene mutations.
Treatment for Pallister Hall Syndrome focuses on managing the individual symptoms and may involve a multidisciplinary approach. This may include surgical interventions for polydactyly or airway abnormalities, hormone replacement therapy for hormonal imbalances, and early intervention programs to support developmental delays.
It is important for individuals with Pallister Hall Syndrome to receive ongoing medical care and support from a team of healthcare professionals to optimize their quality of life and manage any associated complications.